![Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer | PNAS Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer | PNAS](https://www.pnas.org/cms/10.1073/pnas.0702387104/asset/6db75153-a3a6-480c-aabb-e9ebcab2c795/assets/graphic/zpq0330773170002.jpeg)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer | PNAS
![Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/5cf574ef-8908-4aa7-b6a4-6f10f6c37200/feb412702-fig-0005-m.jpg)
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model - Sarcar - 2019 - FEBS Open Bio - Wiley Online Library
![Dysregulated Redox Regulation Contributes to Nuclear EGFR Localization and Pathogenicity in Lung Cancer | Scientific Reports Dysregulated Redox Regulation Contributes to Nuclear EGFR Localization and Pathogenicity in Lung Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-41395-8/MediaObjects/41598_2019_41395_Fig1_HTML.png)
Dysregulated Redox Regulation Contributes to Nuclear EGFR Localization and Pathogenicity in Lung Cancer | Scientific Reports
![Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation | Scientific Reports Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-57153-9/MediaObjects/41598_2019_57153_Fig1_HTML.png)
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation | Scientific Reports
![Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth | Signal Transduction and Targeted Therapy Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00251-2/MediaObjects/41392_2020_251_Fig1_HTML.png)
Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth | Signal Transduction and Targeted Therapy
![Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway](https://www.spandidos-publications.com/article_images/mmr/20/4/MMR-20-04-3317-g03.jpg)
Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway
![A. Western blot analysis for EGFR, pEGFR (Y1068), Akt, pAkt and B. CDH5... | Download Scientific Diagram A. Western blot analysis for EGFR, pEGFR (Y1068), Akt, pAkt and B. CDH5... | Download Scientific Diagram](https://www.researchgate.net/publication/304662889/figure/fig2/AS:393666133807112@1470868728464/A-Western-blot-analysis-for-EGFR-pEGFR-Y1068-Akt-pAkt-and-B-CDH5-in-A549-lung.png)